Viewing Study NCT01900158


Ignite Creation Date: 2025-12-25 @ 12:05 AM
Ignite Modification Date: 2026-01-04 @ 7:51 AM
Study NCT ID: NCT01900158
Status: COMPLETED
Last Update Posted: 2019-10-29
First Post: 2013-05-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas
Sponsor: PCI Biotech AS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module